Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NH
Novo Holdings A/s
13D · 4.9%
|
3.7M | 8.11% | Unchanged | Q4 '25 | 7.7% | |
|
Shares held by quarter
Peak holding3.7M (Q4'25)
Change over 8 quarters+3.7M
Share of the company8.110%
Disclosed stake13D · 4.9%
|
||||||
|
FI
FCPM III Services B.V.
|
3.2M | 7.10% | Unchanged | Q4 '25 | 15.4% | |
|
Shares held by quarter
Peak holding3.2M (Q4'25)
Change over 8 quarters+3.2M
Share of the company7.100%
|
||||||
28 more super investors behind a free account
See every manager holding MapLight Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
TR
T. Rowe Price Small-Cap Stock Fund, Inc.
|
$22.4M | 625.0K | 1.38% | 0.24% | June 30, 2026 |
|
TR
T. Rowe Price Small-Cap Value Fund, Inc.
|
$21.7M | 605.6K | 1.33% | 0.21% | June 30, 2026 |
23 more funds behind a free account
See every fund holding MapLight Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
C
Catalyst4, Inc.
5%+ holder
13D · 49.9%
|
27.5M | 60.61% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...